Selected research
Market Analysis & Forecast
Global Pre-marital and Pre-Pregnancy Genetic Testing Service Market Analysis and Forecast 2026-2032
Market perspective
The global Pre-marital and Pre-Pregnancy Genetic Testing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Pre-marital and Pre-Pregnancy Genetic Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Pre-marital and Pre-Pregnancy Genetic Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Pre-marital and Pre-Pregnancy Genetic Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Pre-marital and Pre-Pregnancy Genetic Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Pre-marital and Pre-Pregnancy Genetic Testing Service include Illumina, Fulgent Genetics, Natera, NxGen MDx, LLC, Sonic Genetics, MedGenome Labs, My Baby Company, Clinical Labs and Eurofins Scientific, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Pre-marital and Pre-Pregnancy Genetic Testing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Pre-marital and Pre-Pregnancy Genetic Testing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Pre-marital and Pre-Pregnancy Genetic Testing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pre-marital and Pre-Pregnancy Genetic Testing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pre-marital and Pre-Pregnancy Genetic Testing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pre-marital and Pre-Pregnancy Genetic Testing Service revenue, projected growth trends, production technology, application and end-user industry.
Pre-marital and Pre-Pregnancy Genetic Testing Service Segment by Company
Illumina
Fulgent Genetics
Natera
NxGen MDx, LLC
Sonic Genetics
MedGenome Labs
My Baby Company
Clinical Labs
Eurofins Scientific
OPKO Health
Gene by Gene
Invitae
Myriad Genetics
Thermo Fisher Scientific
BGI
Berry Genomics
Kingmed Diagnostic
Dian Diagnostics Group
Adicon
Zhongyuan Concord
WuXi AppTec
Novogene
AmoyDx
Centogene
Genoma Group
SRL Inc.
LSI Medience
GC Genome
Seegene
Huizhi Gene
Pre-marital and Pre-Pregnancy Genetic Testing Service Segment by Type
Premarital Genetic Testing
Preconception Genetic Testing
Pre-marital and Pre-Pregnancy Genetic Testing Service Segment by Application
Premarital Population
Couples Planning for Pregnancy
People with a Family History of Genetic Diseases
People Undergoing Assisted Reproductive Technology (IVF)
Pre-marital and Pre-Pregnancy Genetic Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pre-marital and Pre-Pregnancy Genetic Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pre-marital and Pre-Pregnancy Genetic Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pre-marital and Pre-Pregnancy Genetic Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pre-marital and Pre-Pregnancy Genetic Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pre-marital and Pre-Pregnancy Genetic Testing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pre-marital and Pre-Pregnancy Genetic Testing Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Premarital Genetic Testing
- Preconception Genetic Testing
Applications
- Premarital Population
- Couples Planning for Pregnancy
- People with a Family History of Genetic Diseases
- People Undergoing Assisted Reproductive Technology (IVF)
Companies covered
- Illumina
- Fulgent Genetics
- Natera
- NxGen MDx, LLC
- Sonic Genetics
- MedGenome Labs
- My Baby Company
- Clinical Labs
- Eurofins Scientific
- OPKO Health
- Gene by Gene
- Invitae
- Myriad Genetics
- Thermo Fisher Scientific
- BGI
- Berry Genomics
- Kingmed Diagnostic
- Dian Diagnostics Group
- Adicon
- Zhongyuan Concord
- WuXi AppTec
- Novogene
- AmoyDx
- Centogene
- Genoma Group
- SRL Inc.
- LSI Medience
- GC Genome
- Seegene
- Huizhi Gene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Pre-marital and Pre-Pregnancy Genetic Testing Service Market by Type
- 1.2.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Premarital Genetic Testing
- 1.2.3 Preconception Genetic Testing
- 1.3 Pre-marital and Pre-Pregnancy Genetic Testing Service Market by Application
- 1.3.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Premarital Population
- 1.3.3 Couples Planning for Pregnancy
- 1.3.4 People with a Family History of Genetic Diseases
- 1.3.5 People Undergoing Assisted Reproductive Technology (IVF)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pre-marital and Pre-Pregnancy Genetic Testing Service Market Dynamics
- 2.1 Pre-marital and Pre-Pregnancy Genetic Testing Service Industry Trends
- 2.2 Pre-marital and Pre-Pregnancy Genetic Testing Service Industry Drivers
- 2.3 Pre-marital and Pre-Pregnancy Genetic Testing Service Industry Opportunities and Challenges
- 2.4 Pre-marital and Pre-Pregnancy Genetic Testing Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Market Perspective (2021-2032)
- 3.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Growth Trends by Region
- 3.2.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Region (2021-2026)
- 3.2.3 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Players
- 4.1.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Players (2021-2026)
- 4.1.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Key Players Headquarters & Area Served
- 4.4 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Players, Product Type & Application
- 4.5 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Market CR5 and HHI
- 4.6.3 2025 Pre-marital and Pre-Pregnancy Genetic Testing Service Tier 1, Tier 2, and Tier 3
5 Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Type
- 5.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Type (2021-2032)
- 5.3 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue Market Share by Type (2021-2032)
6 Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size by Application
- 6.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Application (2021-2032)
- 6.3 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Illumina
- 7.1.1 Illumina Company Information
- 7.1.2 Illumina Business Overview
- 7.1.3 Illumina Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.1.4 Illumina Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.1.5 Illumina Recent Developments
- 7.2 Fulgent Genetics
- 7.2.1 Fulgent Genetics Company Information
- 7.2.2 Fulgent Genetics Business Overview
- 7.2.3 Fulgent Genetics Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.2.4 Fulgent Genetics Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.2.5 Fulgent Genetics Recent Developments
- 7.3 Natera
- 7.3.1 Natera Company Information
- 7.3.2 Natera Business Overview
- 7.3.3 Natera Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.3.4 Natera Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.3.5 Natera Recent Developments
- 7.4 NxGen MDx, LLC
- 7.4.1 NxGen MDx, LLC Company Information
- 7.4.2 NxGen MDx, LLC Business Overview
- 7.4.3 NxGen MDx, LLC Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.4.4 NxGen MDx, LLC Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.4.5 NxGen MDx, LLC Recent Developments
- 7.5 Sonic Genetics
- 7.5.1 Sonic Genetics Company Information
- 7.5.2 Sonic Genetics Business Overview
- 7.5.3 Sonic Genetics Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.5.4 Sonic Genetics Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.5.5 Sonic Genetics Recent Developments
- 7.6 MedGenome Labs
- 7.6.1 MedGenome Labs Company Information
- 7.6.2 MedGenome Labs Business Overview
- 7.6.3 MedGenome Labs Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.6.4 MedGenome Labs Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.6.5 MedGenome Labs Recent Developments
- 7.7 My Baby Company
- 7.7.1 My Baby Company Company Information
- 7.7.2 My Baby Company Business Overview
- 7.7.3 My Baby Company Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.7.4 My Baby Company Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.7.5 My Baby Company Recent Developments
- 7.8 Clinical Labs
- 7.8.1 Clinical Labs Company Information
- 7.8.2 Clinical Labs Business Overview
- 7.8.3 Clinical Labs Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.8.4 Clinical Labs Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.8.5 Clinical Labs Recent Developments
- 7.9 Eurofins Scientific
- 7.9.1 Eurofins Scientific Company Information
- 7.9.2 Eurofins Scientific Business Overview
- 7.9.3 Eurofins Scientific Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.9.4 Eurofins Scientific Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.9.5 Eurofins Scientific Recent Developments
- 7.10 OPKO Health
- 7.10.1 OPKO Health Company Information
- 7.10.2 OPKO Health Business Overview
- 7.10.3 OPKO Health Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.10.4 OPKO Health Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.10.5 OPKO Health Recent Developments
- 7.11 Gene by Gene
- 7.11.1 Gene by Gene Company Information
- 7.11.2 Gene by Gene Business Overview
- 7.11.3 Gene by Gene Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Gene by Gene Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.11.5 Gene by Gene Recent Developments
- 7.12 Invitae
- 7.12.1 Invitae Company Information
- 7.12.2 Invitae Business Overview
- 7.12.3 Invitae Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.12.4 Invitae Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.12.5 Invitae Recent Developments
- 7.13 Myriad Genetics
- 7.13.1 Myriad Genetics Company Information
- 7.13.2 Myriad Genetics Business Overview
- 7.13.3 Myriad Genetics Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.13.4 Myriad Genetics Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.13.5 Myriad Genetics Recent Developments
- 7.14 Thermo Fisher Scientific
- 7.14.1 Thermo Fisher Scientific Company Information
- 7.14.2 Thermo Fisher Scientific Business Overview
- 7.14.3 Thermo Fisher Scientific Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.14.4 Thermo Fisher Scientific Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.14.5 Thermo Fisher Scientific Recent Developments
- 7.15 BGI
- 7.15.1 BGI Company Information
- 7.15.2 BGI Business Overview
- 7.15.3 BGI Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.15.4 BGI Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.15.5 BGI Recent Developments
- 7.16 Berry Genomics
- 7.16.1 Berry Genomics Company Information
- 7.16.2 Berry Genomics Business Overview
- 7.16.3 Berry Genomics Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.16.4 Berry Genomics Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.16.5 Berry Genomics Recent Developments
- 7.17 Kingmed Diagnostic
- 7.17.1 Kingmed Diagnostic Company Information
- 7.17.2 Kingmed Diagnostic Business Overview
- 7.17.3 Kingmed Diagnostic Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.17.4 Kingmed Diagnostic Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.17.5 Kingmed Diagnostic Recent Developments
- 7.18 Dian Diagnostics Group
- 7.18.1 Dian Diagnostics Group Company Information
- 7.18.2 Dian Diagnostics Group Business Overview
- 7.18.3 Dian Diagnostics Group Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.18.4 Dian Diagnostics Group Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.18.5 Dian Diagnostics Group Recent Developments
- 7.19 Adicon
- 7.19.1 Adicon Company Information
- 7.19.2 Adicon Business Overview
- 7.19.3 Adicon Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.19.4 Adicon Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.19.5 Adicon Recent Developments
- 7.20 Zhongyuan Concord
- 7.20.1 Zhongyuan Concord Company Information
- 7.20.2 Zhongyuan Concord Business Overview
- 7.20.3 Zhongyuan Concord Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.20.4 Zhongyuan Concord Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.20.5 Zhongyuan Concord Recent Developments
- 7.21 WuXi AppTec
- 7.21.1 WuXi AppTec Company Information
- 7.21.2 WuXi AppTec Business Overview
- 7.21.3 WuXi AppTec Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.21.4 WuXi AppTec Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.21.5 WuXi AppTec Recent Developments
- 7.22 Novogene
- 7.22.1 Novogene Company Information
- 7.22.2 Novogene Business Overview
- 7.22.3 Novogene Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.22.4 Novogene Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.22.5 Novogene Recent Developments
- 7.23 AmoyDx
- 7.23.1 AmoyDx Company Information
- 7.23.2 AmoyDx Business Overview
- 7.23.3 AmoyDx Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.23.4 AmoyDx Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.23.5 AmoyDx Recent Developments
- 7.24 Centogene
- 7.24.1 Centogene Company Information
- 7.24.2 Centogene Business Overview
- 7.24.3 Centogene Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.24.4 Centogene Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.24.5 Centogene Recent Developments
- 7.25 Genoma Group
- 7.25.1 Genoma Group Company Information
- 7.25.2 Genoma Group Business Overview
- 7.25.3 Genoma Group Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.25.4 Genoma Group Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.25.5 Genoma Group Recent Developments
- 7.26 SRL Inc.
- 7.26.1 SRL Inc. Company Information
- 7.26.2 SRL Inc. Business Overview
- 7.26.3 SRL Inc. Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.26.4 SRL Inc. Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.26.5 SRL Inc. Recent Developments
- 7.27 LSI Medience
- 7.27.1 LSI Medience Company Information
- 7.27.2 LSI Medience Business Overview
- 7.27.3 LSI Medience Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.27.4 LSI Medience Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.27.5 LSI Medience Recent Developments
- 7.28 GC Genome
- 7.28.1 GC Genome Company Information
- 7.28.2 GC Genome Business Overview
- 7.28.3 GC Genome Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.28.4 GC Genome Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.28.5 GC Genome Recent Developments
- 7.29 Seegene
- 7.29.1 Seegene Company Information
- 7.29.2 Seegene Business Overview
- 7.29.3 Seegene Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.29.4 Seegene Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.29.5 Seegene Recent Developments
- 7.30 Huizhi Gene
- 7.30.1 Huizhi Gene Company Information
- 7.30.2 Huizhi Gene Business Overview
- 7.30.3 Huizhi Gene Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 7.30.4 Huizhi Gene Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 7.30.5 Huizhi Gene Recent Developments
8 North America
- 8.1 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue (2021-2032)
- 8.2 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Type (2021-2032)
- 8.2.1 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Type (2021-2026)
- 8.2.2 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Type (2027-2032)
- 8.3 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue Share by Type (2021-2032)
- 8.4 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Application (2021-2032)
- 8.4.1 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Application (2021-2026)
- 8.4.2 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Application (2027-2032)
- 8.5 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue Share by Application (2021-2032)
- 8.6 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Country
- 8.6.1 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Country (2021-2026)
- 8.6.3 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue (2021-2032)
- 9.2 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Type (2021-2032)
- 9.2.1 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Type (2021-2026)
- 9.2.2 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Type (2027-2032)
- 9.3 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue Share by Type (2021-2032)
- 9.4 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Application (2021-2032)
- 9.4.1 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Application (2021-2026)
- 9.4.2 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Application (2027-2032)
- 9.5 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue Share by Application (2021-2032)
- 9.6 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Country
- 9.6.1 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Country (2021-2026)
- 9.6.3 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue (2021-2032)
- 10.2 China Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Type (2021-2032)
- 10.2.1 China Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Type (2021-2026)
- 10.2.2 China Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Type (2027-2032)
- 10.3 China Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue Share by Type (2021-2032)
- 10.4 China Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Application (2021-2032)
- 10.4.1 China Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Application (2021-2026)
- 10.4.2 China Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Application (2027-2032)
- 10.5 China Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue (2021-2032)
- 11.2 Asia Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Type (2021-2032)
- 11.2.1 Asia Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Type (2021-2026)
- 11.2.2 Asia Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Type (2027-2032)
- 11.3 Asia Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue Share by Type (2021-2032)
- 11.4 Asia Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Application (2021-2032)
- 11.4.1 Asia Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Application (2021-2026)
- 11.4.2 Asia Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Application (2027-2032)
- 11.5 Asia Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue Share by Application (2021-2032)
- 11.6 Asia Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Country
- 11.6.1 Asia Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Country (2021-2026)
- 11.6.3 Asia Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue (2021-2032)
- 12.2 SAMEA Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Type (2027-2032)
- 12.3 SAMEA Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Application (2027-2032)
- 12.5 SAMEA Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Country
- 12.6.1 SAMEA Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst